Details for New Drug Application (NDA): 212168
✉ Email this page to a colleague
The generic ingredient in TAVABOROLE is tavaborole. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tavaborole profile page.
Summary for 212168
Tradename: | TAVABOROLE |
Applicant: | Lupin Ltd |
Ingredient: | tavaborole |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 5% | ||||
Approval Date: | Feb 8, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription